These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16980018)

  • 21. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
    Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
    Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
    Ikegami T; Shimada M; Imura S; Yoshizumi T; Arakawa Y; Tokunaga T; Morine Y; Kanemura H
    Transplantation; 2008 Sep; 86(5):641-6. PubMed ID: 18791443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.
    Yamamoto J; Kosuge T; Saiura A; Sakamoto Y; Shimada K; Sano T; Takayama T; Sugawara Y; Yamaguchi T; Kokudo N; Makuuchi M
    Jpn J Clin Oncol; 2007 Apr; 37(4):287-95. PubMed ID: 17553819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
    Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
    Ataide EC; Boin IF; Almeida JR; Sevá-Pereira T; Stucchi RS; Cardoso AR; Caruy CA; Escanhoela CA
    Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
    Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale PL; Beltrami CA; Bresadola F
    Transplant Proc; 2006 May; 38(4):1111-3. PubMed ID: 16757280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living related liver transplantation for hepatocellular carcinoma in Egypt.
    El-Meteini M; Fayez A; Fathy M; Abdalaal A; Safaan H; Mostafa I; Abdalaal M; Mokhtar A; Salah M; El-Dorry A; Abdalwahab S; El-Monayeri M; Boillot O
    Transplant Proc; 2005 Sep; 37(7):3141-3. PubMed ID: 16213330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milan criteria versus San Francisco criteria in hepatocellular carcinoma: our center's experience.
    Sánchez Antolín G; García Pajares F; Pérez E; Villacastín E; Ruiz Rebollo L; Sánchez DP; Cítores MA; Velicia Llames R
    Transplant Proc; 2009 Apr; 41(3):1012-3. PubMed ID: 19376413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation in patients with hepatocellular carcinoma: one center's experience.
    Karakayali H; Sevmis S; Moray G; Yilmaz U; Ozcay F; Savas NA; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):213-8. PubMed ID: 18261590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year survival after monotherapy for hepatocellular carcinoma in the setting of cirrhosis.
    Fouzas I; Sotiropoulos GC; Sgourakis G; Drühe N; Wohlschlaeger J; Molmenti EP; Broelsch CE; Lang H
    Transplant Proc; 2008 Nov; 40(9):3204-5. PubMed ID: 19010235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.